CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
Status:
Recruiting
Trial end date:
2028-05-02
Target enrollment:
Participant gender:
Summary
Two-parallel groups randomized, single-blinded, multi-center phase III controlled trial in
patients with chronic inflammatory cardiomyopathy to assess the efficacy of colchicine and
associated prospective registry to assess the prognostic value of positive genetic testing in
this population.
Phase:
Phase 3
Details
Lead Sponsor:
Niguarda Hospital
Collaborators:
European Union Mario Negri Institute for Pharmacological Research Ministry of Health, Italy University of Milano Bicocca